Our data showed that no significant differences in serum IL-37 levels with peptic ulcer, liver dysfunction, intestinal tuberculosis, leukocytosis, kidney dysfunction, polycythemia, hyperlipidemia and adult still disease in AS patients (Table 4). Here, IL37 is linked to hyperlipidemia.